Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Albany Medical College
- Study ID
- NCT05629494
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- PSA
- Prostate Cancer
- Prostate Inflammation
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Ibuprofen 400 mg, TID — DRUGParticipants will receive Ibuprofen 400 mg 3 times per day for 10 days.
- PSA test — DIAGNOSTIC_TESTPSA test will be repeated in 6 weeks
Study Details
Prostate cancer is the most frequently diagnosed cancer in men in the Unites States. Nearly 1 million prostate biopsy procedures are performed in the United States annually and elevated prostate-specific antigen (PSA) level is the primary reason for prostate biopsy in \> 90% of cases. However, at the PSA levels which trigger prostate biopsy, often no cancer is found in prostate biopsy specimens. PSA test can be elevated due to reasons other than cancer such as inflammation or natural variation in the level. Investigators plan to treat men with elevated PSA level with over the counter anti-inflammatory medications (ibuprofen, naproxen) to see if the PSA level will decrease to an acceptable level.
Key Dates
- Start date
- Sep 27, 2022
- Status verified
- Oct 2024
- Primary completion
- Mar 1, 2026
- Completion
- Dec 1, 2026
Study Design
- Enrollment
- 198 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Repeat serum PSA testRepeat PSA test at 6 (± 1) weeks, without any treatment
- Experimental: Treatment with NSAIDSTreatment with Ibuprofen 400 mg, 3 times per day, then repeat PSA test at 6 (± 1) weeks
Primary Outcome Measure
Difference in the extent of changes in PSA level between the study groups [ Time Frame: 6 weeks ]
Central Contacts
- Brenda Romeo518-262-8579
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Chicago Medical Center | Chicago | Illinois | 60637 | |
| Albany Medical Center | Albany | New York | 12208 | |
| Penn State-Hershey Medical Center | Hershey | Pennsylvania | 17033 |
Find similar trials in Chicago, IL
Related Studies
- [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate CancerRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical ProstatectomyRecruiting · Proton Collaborative Group · Little Rock, Arkansas
- Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate CancerPHASE3 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado